Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem.

Postgraduate medical journal ·Vol. 66 ·No. 782 ·1990-12-00 ·Pages 1090

Kerr KG, Hawkey PM, Child JA, Norfolk DR, Anderson AW

Abstract

暂无摘要

MeSH Terms

Drug Resistance, Microbial Female Humans Imipenem/therapeutic use Neutropenia/complications Opportunistic Infections/drug therapy Pseudomonas Infections/drug therapy

Chemicals

Imipenem

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Kerr K G

Hawkey P M

Child J A

Norfolk D R

Anderson A W

References (5)

5 references, click to expand

Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature.
Rev Infect Dis. 1982 Nov-Dec;4(6):1236-46 PMID: 7156659
Thienamycin: development of imipenen-cilastatin.
J Antimicrob Chemother. 1983 Dec;12 Suppl D:1-35 PMID: 6365872
Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum.
Arch Intern Med. 1987 Sep;147(9):1672-4 PMID: 3632174
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Antimicrob Agents Chemother. 1986 Aug;30(2):211-4 PMID: 3532942
Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections.
Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S452-7 PMID: 3901207

Article Info

Journal

Postgraduate medical journal

Abbr.

Postgrad Med J

ISSN

0032-5473

DOI

10.1136/pgmj.66.782.1090

Published

1990-12-00

Pages

1090

Language

English

Region

England

NLM ID

0234135

PMCID

PMC2429775

Subset

External Links

PubMed source DOI: 10.1136/pgmj.66.782.1090 PMC Full Text View journal details

Analysis Services

Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem.

Contact

WeChat Official Account